Epithelioid Mesothelioma

Epithelioid mesothelioma is a subtype of malignant mesothelioma characterized by epithelial-like cancer cells. It is the most common mesothelioma cell type, accounting for 50% to 70% of all diagnoses. While still aggressive and life-threatening, epithelioid mesothelioma generally responds better to treatment and carries a more favorable prognosis than sarcomatoid or biphasic mesothelioma.

Epithelioid mesothelioma is the most common and most treatable mesothelioma cell type, though it remains a serious asbestos-related cancer.

What Is Epithelioid Mesothelioma?

Epithelioid mesothelioma is defined by the shape and behavior of its cancer cells. Under a microscope, epithelioid cells appear uniform, elongated, and arranged in structured patterns resembling healthy epithelial tissue. This organized structure often makes the cancer easier to identify and, in some cases, more responsive to treatment.

Epithelioid mesothelioma can develop in several areas of the body, including:

? Pleura (lung lining) � most common
? Peritoneum (abdominal lining)
? Pericardium (heart lining)
? Tunica vaginalis (testicular lining, rare)

Epithelioid Mesothelioma Facts

? Most common mesothelioma cell type
? Generally associated with better prognosis
? Caused primarily by asbestos exposure
? Diagnosis requires imaging and biopsy
? Treatment may include surgery, chemotherapy, immunotherapy, and radiation
? Survival outcomes are often better than with sarcomatoid mesothelioma

Why Choose Us for Your Asbestos Exposure Claim?

Free No-Obligation Review

We provide free no-obligation A. B. Barone asbestos exposure case review

Contingency Representation

We work on a contingency basis, meaning there are no fees unless we collect for you

Expertise In Asbestos & Mesothelioma Lawsuits

We have experience winning claims against huge multi-national corporations

Symptoms of Epithelioid Mesothelioma

Symptoms may take 20 to 50 years to appear after asbestos exposure. Early symptoms are often mild and nonspecific, which can delay diagnosis.

Common symptoms include:

? Chest or abdominal pain
? Shortness of breath
? Persistent cough
? Fatigue
? Unexplained weight loss
? Fluid buildup around the lungs or abdomen

Symptoms vary depending on where the cancer develops. Pleural epithelioid mesothelioma primarily affects breathing, while peritoneal cases may cause abdominal swelling and digestive issues.

Diagnosis of Epithelioid Mesothelioma

Diagnosis typically begins with imaging tests such as X-rays, CT scans, or MRIs to detect abnormalities or fluid buildup. If mesothelioma is suspected, a biopsy is required to confirm the diagnosis and determine the cell type.

Pathologists examine tissue samples under a microscope to identify epithelioid cells and rule out other cancers. Immunohistochemistry may also be used to distinguish epithelioid mesothelioma from similar-appearing tumors.

Accurate identification of the cell type is essential, as it significantly influences treatment planning and prognosis.

Prognosis and Treatment Options

Epithelioid mesothelioma generally carries a more favorable prognosis than other mesothelioma subtypes. Patients with this cell type are often eligible for more aggressive treatment approaches, especially when diagnosed early.

Treatment options may include:

? Surgical tumor removal
? Chemotherapy
? Immunotherapy
? Radiation therapy
? Multimodal treatment combining several approaches

Treatment plans are tailored to each patient based on cancer stage, tumor location, overall health, and response to therapy. While epithelioid mesothelioma is not curable, treatment can extend survival and improve quality of life.

Staging of Epithelioid Mesothelioma

Staging determines how far the cancer has spread and guides treatment decisions. The TNM staging system�Tumor, Node, Metastasis�is commonly used for pleural epithelioid mesothelioma.

Early stages indicate localized disease with limited spread, while advanced stages involve lymph nodes or distant organs. Identifying the stage helps specialists recommend the most appropriate treatment strategy and provide clearer expectations for patients and families.